SPCC (Sharing Progress in Cancer Care) shared a post on Linkedin:
”It is available now on our website Aleksandra Filipovic‘s inspirational interview with Dr. Brian Druker, the esteemed director of the OHSU Knight Cancer Institute.
Known for his groundbreaking work in cancer research, Dr. Druker developed Gleevec, a targeted therapy that revolutionised the treatment of chronic myeloid leukemia (CML) by attacking cancer cells while preserving healthy ones.
In the interview, Dr. Druker reflects on the key milestones of his life and career, from his early days to his present work. Every new drug has a human who has championed it to existence, who persevered, who believed. Who knew the ‘Why’ and therefore found the ‘How’. ”
Additional information.
Source: SPCC/Linkedin